IRP-2 Antibodies

Santa Cruz Biotechnology offers a broad range of IRP-2 monoclonal antibodies for research in understanding iron metabolism and regulation. IRP-2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Iron Regulatory Protein 2 (IRP-2) plays a crucial role in cellular iron homeostasis by regulating the expression of proteins involved in iron uptake, storage, and utilization. Dysregulation of IRP-2 has been implicated in various diseases, including neurodegenerative disorders and cancer, making it an important target for research. Understanding the function and regulation of IRP-2 is essential for developing therapeutic strategies aimed at restoring iron balance in affected tissues. Research into IRP-2 continues to reveal new insights about its role in maintaining cellular health and disease progression. Investigating IRP-2's molecular interactions provides valuable information about iron metabolism pathways and potential therapeutic interventions. Current studies focus on understanding how IRP-2 responds to varying iron conditions and oxidative stress. Santa Cruz Biotechnology monoclonal antibodies for IRP-2 enable researchers worldwide to advance our understanding of iron regulation and its impact on human health.